BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34119141)

  • 1. Hyaluronic acid based microneedle array: Recent applications in drug delivery and cosmetology.
    Saha I; Rai VK
    Carbohydr Polym; 2021 Sep; 267():118168. PubMed ID: 34119141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine polymeric microneedles for transdermal drug delivery.
    Moniz T; Costa Lima SA; Reis S
    Carbohydr Polym; 2021 Aug; 266():118098. PubMed ID: 34044917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PVP-microneedle array for drug delivery: mechanical insight, biodegradation, and recent advances.
    Mangang KN; Thakran P; Halder J; Yadav KS; Ghosh G; Pradhan D; Rath G; Rai VK
    J Biomater Sci Polym Ed; 2023 May; 34(7):986-1017. PubMed ID: 36541167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedle Array Patch (MAP) Consisting of Crosslinked Hyaluronic Acid Nanoparticles for Processability and Sustained Release.
    Kim DS; Choi JT; Kim CB; Shin YR; Park PG; Kim H; Lee JM; Park JH
    Pharm Res; 2020 Feb; 37(3):50. PubMed ID: 32034526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
    Al-Qallaf B; Das DB
    J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-oleylamine and chitosan-oleic acid conjugate-based hybrid nanoparticle delivery via. dissolving microneedles for enhanced treatment efficacy in localized breast cancer.
    Jha A; Kumar M; Goswami P; Manjit M; Bharti K; Koch B; Mishra B
    Biomater Adv; 2024 Jun; 160():213865. PubMed ID: 38643693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of hyaluronic acid-silica composites via in situ precipitation for improved penetration efficiency in fast-dissolving microneedle systems.
    Tay JH; Lim YH; Zheng M; Zhao Y; Tan WS; Xu C; Ramamurty U; Song J
    Acta Biomater; 2023 Dec; 172():175-187. PubMed ID: 37865280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of molecular weight of hyaluronic acid on transdermal delivery efficiencies of dissolving microneedles.
    Chi Y; Huang Y; Kang Y; Dai G; Liu Z; Xu K; Zhong W
    Eur J Pharm Sci; 2022 Jan; 168():106075. PubMed ID: 34813921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedles and transdermal applications.
    Sivamani RK; Liepmann D; Maibach HI
    Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolving Hyaluronic Acid-Based Microneedles to Transdermally Deliver Eugenol Combined with Photothermal Therapy for Acne Vulgaris Treatment.
    Wang Q; Gan Z; Wang X; Li X; Zhao L; Li D; Xu Z; Mu C; Ge L; Li D
    ACS Appl Mater Interfaces; 2024 May; 16(17):21595-21609. PubMed ID: 38635857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations in the use of microneedles: pain, convenience, anxiety and safety.
    Jeong HR; Lee HS; Choi IJ; Park JH
    J Drug Target; 2017 Jan; 25(1):29-40. PubMed ID: 27282644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonically and Iontophoretically Enhanced Drug-Delivery System Based on Dissolving Microneedle Patches.
    Bok M; Zhao ZJ; Jeon S; Jeong JH; Lim E
    Sci Rep; 2020 Feb; 10(1):2027. PubMed ID: 32029808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedle patch based on dissolving, detachable microneedle technology for improved skin quality - Part 1: ex vivo safety evaluation.
    Zvezdin V; Peno-Mazzarino L; Radionov N; Kasatkina T; Kasatkin I
    Int J Cosmet Sci; 2020 Aug; 42(4):369-376. PubMed ID: 32412648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
    Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
    Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The most promising microneedle device: present and future of hyaluronic acid microneedle patch.
    Kang H; Zuo Z; Lin R; Yao M; Han Y; Han J
    Drug Deliv; 2022 Dec; 29(1):3087-3110. PubMed ID: 36151726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.